[en] Carbohydrates play major roles in host-virus interactions. It is therefore not surprising that, during coevolution with their hosts, viruses have developed sophisticated mechanisms to hijack for their profit different pathways of glycan synthesis. Thus, the Bo17 gene of Bovine herpesvirus 4 (BoHV-4) encodes a homologue of the cellular core 2 protein beta-1,6-N-acetylglucosaminyltransferase-mucin type (C2GnT-M), which is a key player for the synthesis of complex O-glycans. Surprisingly, we show in this study that, as opposed to what is observed for the cellular enzyme, two different mRNAs are encoded by the Bo17 gene of all available BoHV-4 strains. While the first one corresponds to the entire coding sequence of the Bo17 gene, the second results from the splicing of a 138-bp intron encoding critical residues of the enzyme. Antibodies generated against the Bo17 C terminus showed that the two forms of Bo17 are expressed in BoHV-4 infected cells, but enzymatic assays revealed that the spliced form is not active. In order to reveal the function of these two forms, we then generated recombinant strains expressing only the long or the short form of Bo17. Although we did not highlight replication differences between these strains, glycomic analyses and lectin neutralization assays confirmed that the splicing of the Bo17 gene gives the potential to BoHV-4 to fine-tune the global level of core 2 branching activity in the infected cell. Altogether, these results suggest the existence of new mechanisms to regulate the activity of glycosyltransferases from the Golgi apparatus. IMPORTANCE: Viruses are masters of adaptation that hijack cellular pathways to allow their growth. Glycans play a central role in many biological processes, and several studies have highlighted mechanisms by which viruses can affect glycosylation. Glycan synthesis is a nontemplate process regulated by the availability of key glycosyltransferases. Interestingly, bovine herpesvirus 4 encodes one such enzyme which is a key enzyme for the synthesis of complex O-glycans. In this study, we show that, in contrast to cellular homologues, this virus has evolved to alternatively express two proteins from this gene. While the first one is enzymatically active, the second results from the alternative splicing of the region encoding the catalytic site of the enzyme. We postulate that this regulatory mechanism could allow the virus to modulate the synthesis of some particular glycans for function at the location and/or the moment of infection.
Disciplines :
Microbiology
Author, co-author :
Lété, Céline ; Université de Liège > Département des maladies infectieuses et parasitaires (DMI) > Vaccinologie vétérinaire
Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. 2001. Glycosylation and the immune system. Science +291:2370-2376. http://dx.doi.org/10.1126/science.291.5512.2370.
Rudd PM, Wormald MR, Dwek RA. 2004. Sugar-mediated ligandreceptor interactions in the immune system. Trends Biotechnol 22:524-530. http://dx.doi.org/10.1016/j.tibtech.2004.07.012.
Tian E, Ten Hagen KG. 2009. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J 26:325-334. http://dx.doi.org/10.1007/s10719-008-9162-4.
Lowe JB, Marth JD. 2003. A genetic approach to mammalian glycan function. Annu Rev Biochem 72:643-691. http://dx.doi.org/10.1146/annurev.biochem.72.121801.161809.
Stone EL, Ismail MN, Lee SH, Luu Y, Ramirez K, Haslam SM, Ho SB, Dell A, Fukuda M, Marth JD. 2009. Glycosyltransferase function in core 2-type proteinOglycosylation. Mol Cell Biol 29:3770-3782. http://dx.doi.org/10.1128/MCB.00204-09.
Gauguet JM, Rosen SD, Marth JD, von Andrian UH. 2004. Core 2 branching β1,6-N-acetylglucosaminyltransferase and high endothelial cell N-acetylglucosamine-6-sulfotransferase exert differential control over B-and T-lymphocyte homing to peripheral lymph nodes. Blood 104:4104-4112. http://dx.doi.org/10.1182/blood-2004-05-1986.
Schwientek T, Yeh JC, Levery SB, Keck B, Merkx G, van Kessel AG, Fukuda M, Clausen H. 2000. Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 β1,6-N-acetylglucosaminyltransferase. J Biol Chem 275:11106-11113. ur.
Bagdonaite I, Norden R, Joshi HJ, Dabelsteen S, Nystrom K, Vakhrushev SY, Olofsson S, Wandall HH. 2015. A strategy for Oglycoproteomics of enveloped viruses: the O-glycoproteome of herpes simplex virus type 1. PLoS Pathog 11:e1004784. http://dx.doi.org/10.1371/journal.ppat.1004784.
Vigerust DJ, Shepherd VL. 2007. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15:211-218. http://dx.doi.org/10.1016/j.tim.2007.03.003.
Markine-Goriaynoff N, Gillet L, Van Etten JL, Korres H, Verma N, Vanderplasschen A. 2004. Glycosyltransferases encoded by viruses. J Gen Virol 85:2741-2754. http://dx.doi.org/10.1099/vir.0.80320-0.
Wilkie GS, Davison AJ, Watson M, Kerr K, Sanderson S, Bouts T, Steinbach F, Dastjerdi A. 2013. Complete genome sequences of elephant endotheliotropic herpesviruses 1A and 1B determined directly from fatal cases. J Virol 87:6700-6712. http://dx.doi.org/10.1128/JVI.00655-13.
Vanderplasschen A, Markine-Goriaynoff N, Lomonte P, Suzuki M, Hiraoka N, Yeh JC, Bureau F, Willems L, Thiry E, Fukuda M, Pastoret PP. 2000. A multipotential beta -1,6-N-acetylglucosaminyl-transferase is encoded by bovine herpesvirus type 4. Proc Natl Acad Sci U S A 97:5756-5761. http://dx.doi.org/10.1073/pnas.100058897.
Thiry E, Bublot M, Dubuisson J, Van Bressem MF, Lequarre AS, Lomonte P, Vanderplasschen A, Pastoret PP. 1992. Molecular biology of bovine herpesvirus type 4. Vet Microbiol 33:79-92. http://dx.doi.org/10.1016/0378-1135(92)90037-T.
Palmeira L, Machiels B, Lete C, Vanderplasschen A, Gillet L. 2011. Sequencing of bovine herpesvirus 4 V.test strain reveals important genome features. Virol J 8:406. http://dx.doi.org/10.1186/1743-422X-8-406.
Zimmermann W, Broll H, Ehlers B, Buhk HJ, Rosenthal A, Goltz M. 2001. Genome sequence of bovine herpesvirus 4, a bovine rhadinovirus, and identification of an origin of DNA replication. J Virol 75:1186-1194. http://dx.doi.org/10.1128/JVI.75.3.1186-1194.2001.
Markine-Goriaynoff N, Georgin JP, Goltz M, Zimmermann W, Broll H, Wamwayi HM, Pastoret PP, Sharp PM, Vanderplasschen A. 2003. The core 2 beta-1,6-N-acetylglucosaminyltransferase-mucin encoded by bovine herpesvirus 4 was acquired from an ancestor of the African buffalo. J Virol 77:1784-1792. http://dx.doi.org/10.1128/JVI.77.3.1784-1792.2003.
Markine-Goriaynoff N, Gillet L, Karlsen OA, Haarr L, Minner F, Pastoret PP, Fukuda M, Vanderplasschen A. 2004. The core 2 beta-1,6-N-acetylglucosaminyltransferase-M encoded by bovine herpesvirus 4 is not essential for virus replication despite contributing to posttranslational modifications of structural proteins. J Gen Virol 85:355-367. http://dx.doi.org/10.1099/vir.0.19715-0.
Donofrio G, van Santen VL. 2001. A bovine macrophage cell line supports bovine herpesvirus-4 persistent infection. J Gen Virol 82:1181-1185. http://dx.doi.org/10.1099/0022-1317-82-5-1181.
Huynh HT, Robitaille G, Turner JD. 1991. Establishment of bovine mammary epithelial cells (MAC-T): an in vitro model for bovine lactation. Exp Cell Res 197:191-199. http://dx.doi.org/10.1016/0014-4827(91)90422-Q.
Dubuisson J, Guillaume J, Boulanger D, Thiry E, Bublot M, Pastoret PP. 1990. Neutralization of bovine herpesvirus type 4 by pairs of monoclonal antibodies raised against two glycoproteins and identification of antigenic determinants involved in neutralization. J Gen Virol 71:647-653. http://dx.doi.org/10.1099/0022-1317-71-3-647.
Bierhuizen MF, Fukuda M. 1992. Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc Natl Acad Sci U S A 89:9326-9330. http://dx.doi.org/10.1073/pnas.89.19.9326.
Thomas A, Sachse K, Farnir F, Dizier I, Mainil J, Linden A. 2003. Adherence of Mycoplasma bovis to bovine bronchial epithelial cells. Microb Pathog 34:141-148. http://dx.doi.org/10.1016/S0882-4010(03)00003-2.
Thiry E, Pastoret P-P, Dessy-Doizé C, Hanzen C, Calberg-Bacq CM, Dagenaix L, Vindevogel H, Ectors F. 1981. Réactivation d'un herpèsvirus en culture de cellules testiculaires prélevées chez un taureau atteint d'orchite et d'azoospermie. Ann Méd Vét 125:207-214.
Gillet L, Alenquer M, Glauser DL, Colaco S, May JS, Stevenson PG. 2009. Glycoprotein L sets the neutralization profile of murid herpesvirus 4. J Gen Virol 90:1202-1214. http://dx.doi.org/10.1099/vir.0.008755-0.
Machiels B, Lete C, Guillaume A, Mast J, Stevenson PG, Vanderplasschen A, Gillet L. 2011. Antibody evasion by a gammaherpesvirus O-glycan shield. PLoS Pathog 7:e1002387. http://dx.doi.org/10.1371/journal.ppat.1002387.
Lete C, Machiels B, Stevenson PG, Vanderplasschen A, Gillet L. 2012. Bovine herpesvirus type 4 glycoprotein L is nonessential for infectivity but triggers virion endocytosis during entry. J Virol 86:2653-2664. http://dx.doi.org/10.1128/JVI.06238-11.
Yeh JC, Ong E, Fukuda M. 1999. Molecular cloning and expression of a novel beta-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches. J Biol Chem 274:3215-3221. http://dx.doi.org/10.1074/jbc.274.5.3215.
Gillet L, Daix V, Donofrio G, Wagner M, Koszinowski UH, China B, Ackermann M, Markine-Goriaynoff N, Vanderplasschen A. 2005. Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. J Gen Virol 86:907-917. http://dx.doi.org/10.1099/vir.0.80718-0.
Gillet L, May JS, Stevenson PG. 2009. In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection. J Gen Virol 90:602-613. http://dx.doi.org/10.1099/vir.0.005785-0.
Machiels B, Stevenson PG, Vanderplasschen A, Gillet L. 2013. A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization. PLoS Pathog 9:e1003753. http://dx.doi.org/10.1371/journal.ppat.1003753.
Lete C, Palmeira L, Leroy B, Mast J, Machiels B, Wattiez R, Vanderplasschen A, Gillet L. 2012. Proteomic characterization of bovine herpesvirus 4 extracellular virions. J Virol 86:11567-11580. http://dx.doi.org/10.1128/JVI.00456-12.
Jang-Lee J, North SJ, Sutton-Smith M, Goldberg D, Panico M, Morris H, Haslam S, Dell A. 2006. Glycomic profiling of cells and tissues by mass spectrometry: fingerprinting and sequencing methodologies. Methods Enzymol 415:59-86. http://dx.doi.org/10.1016/S0076-6879(06)15005-3.
Kolarich D, Rapp E, Struwe WB, Haslam SM, Zaia J, McBride R, Agravat S, Campbell MP, Kato M, Ranzinger R, Kettner C, York WS. 2013. The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting massspectrometry-based glycoanalytic data. Mol Cell Proteomics 12:991-995. http://dx.doi.org/10.1074/mcp.O112.026492.
Patel AA, Steitz JA. 2003. Splicing double: insights from the second spliceosome. Nat Rev Mol Cell Biol 4:960-970. http://dx.doi.org/10.1038/nrm1259.
Pak JE, Arnoux P, Zhou S, Sivarajah P, Satkunarajah M, Xing X, Rini JM. 2006. X-ray crystal structure of leukocyte type core 2 beta1,6-Nacetylglucosaminyltransferase. Evidence for a convergence of metal ionindependent glycosyltransferase mechanism. J Biol Chem 281:26693-26701. http://dx.doi.org/10.1074/jbc.M60353400.
Pak JE, Satkunarajah M, Seetharaman J, Rini JM. 2011. Structural and mechanistic characterization of leukocyte-type core 2 beta1,6-Nacetylglucosaminyltransferase: a metal-ion-independent GT-A glycosyltransferase. J Mol Biol 414:798-811. http://dx.doi.org/10.1016/j.jmb.2011.10.039.
Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB, Schjoldager KT, Lavrsen K, Dabelsteen S, Pedersen NB, Marcos-Silva L, Gupta R, Bennett EP, Mandel U, Brunak S, Wandall HH, Levery SB, Clausen H. 2013. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 32:1478-1488. http://dx.doi.org/10.1038/emboj.2013.79.
Machiels B, Lete C, de Fays K, Mast J, Dewals B, Stevenson PG, Vanderplasschen A, Gillet L. 2011. The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects. J Virol 85:1011-1024. http://dx.doi.org/10.1128/JVI.01092-10.
Tachibana K, Nakamura S, Wang H, Iwasaki H, Maebara K, Cheng L, Hirabayashi J, Narimatsu H. 2006. Elucidation of binding specificity of Jacalin toward O-glycosylated peptides: quantitative analysis by frontal affinity chromatography. Glycobiology 16:46 -53. http://dx.doi.org/10.1093/glycob/cwj038.
Gillet L, Stevenson PG. 2007. Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B. EMBOJ 26:5131-5142. http://dx.doi.org/10.1038/sj.emboj.7601925.
Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521. http://dx.doi.org/10.1038/386517a0.
Ismail MN, Stone EL, Panico M, Lee SH, Luu Y, Ramirez K, Ho SB, Fukuda M, Marth JD, Haslam SM, Dell A. 2011. High-sensitivity Oglycomic analysis of mice deficient in core 2 β1,6-N-acetylglucosaminyltransferases. Glycobiology 21:82-98. http://dx.doi.org/10.1093/glycob/cwq134.
Tu L, Banfield DK. 2010. Localization of Golgi-resident glycosyltransferases. Cell Mol Life Sci 67:29-41. http://dx.doi.org/10.1007/s00018-009-0126-z.
Aoki D, Lee N, Yamaguchi N, Dubois C, Fukuda MN. 1992. Golgi retention of a trans-Golgi membrane protein, galactosyltransferase, requires cysteine and histidine residues within the membrane-anchoring domain. Proc Natl Acad Sci U S A 89:4319-4323. http://dx.doi.org/10 .1073/pnas.89.10.4319.
Chen C, Ma J, Lazic A, Backovic M, Colley KJ. 2000. Formation of insoluble oligomers correlates with ST6Gal I stable localization in the Golgi. J Biol Chem 275:13819-13826. http://dx.doi.org/10.1074/jbc.275.18.13819.
Hoe MH, Slusarewicz P, Misteli T, Watson R, Warren G. 1995. Evidence for recycling of the resident medial/trans Golgi enzyme, Nacetylglucosaminyltransferase I, in ldlD cells. J Biol Chem 270:25057-25063. http://dx.doi.org/10.1074/jbc.270.42.25057.
Pejchal R, Doores KJ, Walker LM, Khayat R, Huang PS, Wang SK, Stanfield RL, Julien JP, Ramos A, Crispin M, Depetris R, Katpally U, Marozsan A, Cupo A, Maloveste S, Liu Y, McBride R, Ito Y, Sanders RW, Ogohara C, Paulson JC, Feizi T, Scanlan CN, Wong CH, Moore JP, Olson WC, Ward AB, Poignard P, Schief WR, Burton DR, Wilson IA. 2011. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334:1097-1103. http://dx.doi.org/10.1126/science.1213256.
Scanlan CN, Offer J, Zitzmann N, Dwek RA. 2007. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446:1038-1045. http://dx.doi.org/10.1038/nature05818.
Scanlan CN, Pantophlet R, Wormald MR, Ollmann Saphire E, Stanfield R, Wilson IA, Katinger H, Dwek RA, Rudd PM, Burton DR. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of 1-2 mannose residues on the outer face of gp120. J Virol 76:7306-7321. http://dx.doi.org/10.1128/JVI.76.14.7306-7321.2002.
Walker LM, Sok D, Nishimura Y, Donau O, Sadjadpour R, Gautam R, Shingai M, Pejchal R, Ramos A, Simek MD, Geng Y, Wilson IA, Poignard P, Martin MA, Burton DR. 2011. Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque. Proc Natl Acad Sci U S A 108:20125-20129. http://dx.doi.org/10.1073/pnas.1117531108.
Crispin M, Doores KJ. 2015. Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design. Curr Opin Virol 11:63-69. http://dx.doi.org/10.1016/j.coviro.2015.02.002.
Clo E, Kracun SK, Nudelman AS, Jensen KJ, Liljeqvist JA, Olofsson S, Bergstrom T, Blixt O. 2012. Characterization of the viral Oglycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis. J Virol 86:6268-6278. http://dx.doi.org/10.1128/JVI.00392-12.
D'Arrigo I, Clo E, Bergstrom T, Olofsson S, Blixt O. 2013. Diverse IgG serum response to novel glycopeptide epitopes detected within immunodominant stretches of Epstein-Barr virus glycoprotein 350/220: diagnostic potential of O-glycopeptide microarrays. Glycoconj J 30:633-640. http://dx.doi.org/10.1007/s10719-012-9465-3.
Francois S, Vidick S, Sarlet M, Desmecht D, Drion P, Stevenson PG, Vanderplasschen A, Gillet L. 2013. Illumination of murine gammaherpesvirus-68 cycle reveals a sexual transmission route from females to males in laboratory mice. PLoS Pathog 9:e1003292. http://dx.doi.org/10.1371/journal.ppat.1003292.
Fabian K, Ivanics R, Terenyi M, Egyed L. 2005. Detection of bovine herpesvirus 4 in CD11b+ leukocytes of experimentally infected rabbits. Acta Vet Hung 53:265-273. http://dx.doi.org/10.1556/AVet.53.2005.2.12.
Haslam SM, Julien S, Burchell JM, Monk CR, Ceroni A, Garden OA, Dell A. 2008. Characterizing the glycome of the mammalian immune system. Immunol Cell Biol 86:564-573. http://dx.doi.org/10.1038/icb.2008.54.
Julien S, Grimshaw MJ, Sutton-Smith M, Coleman J, Morris HR, Dell A, Taylor-Papadimitriou J, Burchell JM. 2007. Sialyl-Lewis (X) on Pselectin glycoprotein ligand-1 is regulated during differentiation and maturation of dendritic cells: a mechanism involving the glycosyltransferases C2GnT1 and ST3Gal I. J Immunol 179:5701-5710. http://dx.doi.org/10.4049/jimmunol.179.9.5701.
Sperandio M, Gleissner CA, Ley K. 2009. Glycosylation in immune cell trafficking. Immunol Rev 230:97-113. http://dx.doi.org/10.1111/j.1600-065X.2009.00795.x.
Frederico B, Milho R, May JS, Gillet L, Stevenson PG. 2012. Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4. PLoS Pathog 8:e1002935. http://dx.doi.org/10.1371/journal.ppat.1002935.
Gaspar M, May JS, Sukla S, Frederico B, Gill MB, Smith CM, Belz GT, Stevenson PG. 2011. Murid herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathog 7:e1002346. http://dx.doi.org/10.1371/journal.ppat.1002346.
Rouleau M, Roberge J, Falardeau SA, Villeneuve L, Guillemette C. 2013. The relative protein abundance of UGT1A alternative splice variants as a key determinant of glucuronidation activity in vitro. Drug Metab Dispos 41:694-697. http://dx.doi.org/10.1124/dmd.112.050468.